Germline Testing Identifies Pathogenic/Likely Pathogenic Variants in Patients with Pancreatic Neuroendocrine Tumors.

Overview of attention for article published in Cancer Prevention Research, April 2024

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

twitter: 19 X users

reddit: 1 Redditor

Readers on

mendeley: 14 Mendeley

So far, Altmetric has seen 20 X posts from 19 X users, with an upper bound of 49,384 followers.

21% of unselected #pancreatic #neuroendocrinetumor (pNET) #patients w/ #genetictesting had PGVs, the majority in DDR pathway genes. The findings support upfront #universal #germlinetesting in all #patients w/ #pNET. c/w https://t.co/tFSemI4b2i… @JCOPO_A…

RT @Aiims1742: In @CAPR_AACR from @hopkinskimmel & @MDAndersonNews #PancreaticCancer teams: Germline Testing identifies Pathogenic/Likely P…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 16 additional X posts.